Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.
Dalal K, Roshan-Moniri M, Sharma A, Li H, Ban F, Hassona MD, Hsing M, Singh K, LeBlanc E, Dehm S, Tomlinson Guns ES, Cherkasov A, Rennie PS.
Dalal K, et al.
J Biol Chem. 2015 Oct 23;290(43):25850. doi: 10.1074/jbc.A115.553818.
J Biol Chem. 2015.
PMID: 26500294
Free PMC article.
No abstract available.